The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports

Epidermal growth factor receptor (EGFR) is an established driver gene in non-small cell lung cancer (NSCLC) and the common Exon 19 del mutation (p.E746_A750 del) has exhibited remarkable responses for EGFR tyrosine kinase inhibitors (TKIs). However, there is even less comprehension of the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Yamin, Li, Xiaodong, Zhang, Lei, Ye, Minhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546178/
https://www.ncbi.nlm.nih.gov/pubmed/37795433
http://dx.doi.org/10.3389/fonc.2023.1129629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546178/
https://www.ncbi.nlm.nih.gov/pubmed/37795433
http://dx.doi.org/10.3389/fonc.2023.1129629

Ejemplares similares